Immuneering Co News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immuneering co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immuneering Co Today - Breaking & Trending Today

Immuneering Co. (NASDAQ:IMRX) Given Consensus Recommendation of "Moderate Buy" by Analysts

Immuneering Co. (NASDAQ:IMRX) Given Consensus Recommendation of "Moderate Buy" by Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Anne Berman , Jefferies Financial Group , Immuneering Co , Immuneering Company Profile , Financial Services Group Inc , Immuneering Corporation , Needham Company , Corton Capital Inc , Exchange Traded Concepts , Securities Exchange Commission , Get Free Report , Financial Group , Director Ann , Exchange Commission , Cormorant Asset Management , Traded Concepts , Capital Partners , Services Group , Get Free , Investigational New Drug , Immuneering Daily ,

Immuneering Co. (NASDAQ:IMRX) Director Purchases $63,750.00 in Stock

Immuneering Co. (NASDAQ:IMRX – Get Free Report) Director Peter Feinberg acquired 25,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $2.55 per share, for a total transaction of $63,750.00. Following the completion of the acquisition, the director now directly owns 111,766 shares […] ....

Peter Feinberg , Immuneering Company Profile , Virtu Financial , Nuveen Asset Management , Immuneering Corporation , Vanguard Group Inc , Securities Exchange Commission , Jefferies Financial Group , Oracle Alpha Inc , Immuneering Co , Needham Company , Barclays Plc , Get Free Report , Director Peter Feinberg , Exchange Commission , Stock Down , Asset Management , Oracle Alpha , Financial Group , Chardan Capital , Investigational New Drug , Immuneering Daily , Nasdaq Imrx , Insider Trading , Nsider Trades ,

Immuneering Co. (NASDAQ:IMRX) Insider Acquires $10,023.00 in Stock

Immuneering Co. (NASDAQ:IMRX – Get Free Report) insider Harold Eugene Brakewood bought 3,900 shares of the stock in a transaction that occurred on Friday, March 22nd. The stock was bought at an average cost of $2.57 per share, for a total transaction of $10,023.00. Following the completion of the purchase, the insider now directly owns […] ....

United States , Harold Eugene Brakewood , Jefferies Financial Group , American International Group Inc , Needham Company , Immuneering Co , Tower Research Capital , Immuneering Company Profile , Immuneering Corporation , Get Free Report , Stock Down , Research Capital , State Teachers Retirement System , Quantitative Strategies , American International Group , International Group , Financial Group , Investigational New Drug , Immuneering Daily , Nasdaq Imrx , Insider Trading , Nsider Trades ,

Insider Buying: Immuneering Co. (NASDAQ:IMRX) Director Acquires 25,000 Shares of Stock

Immuneering Co. (NASDAQ:IMRX – Get Free Report) Director Peter Feinberg bought 25,000 shares of the company’s stock in a transaction dated Friday, March 22nd. The stock was bought at an average cost of $2.55 per share, for a total transaction of $63,750.00. Following the acquisition, the director now owns 111,766 shares of the company’s stock, […] ....

Peter Feinberg , Needham Company , Pricet Rowe Associates Inc , Immuneering Co , Jefferies Financial Group , Vanguard Group Inc , Immuneering Corporation , Blackrock Inc , Citadel Advisors , Get Free Report , Director Peter Feinberg , Trading Down , Asset Management , Vanguard Group , Investigational New Drug , Immuneering Daily ,

Immuneering Co. (NASDAQ:IMRX) Insider Purchases 3,900 Shares

Immuneering Co. (NASDAQ:IMRX – Get Free Report) insider Harold Eugene Brakewood bought 3,900 shares of the company’s stock in a transaction on Friday, March 22nd. The stock was bought at an average price of $2.57 per share, with a total value of $10,023.00. Following the completion of the acquisition, the insider now owns 3,900 shares […] ....

Harold Eugene Brakewood , York Mellon Corp , Immuneering Corporation , Blackrock Inc , Jpmorgan Chase Co , Vanguard Group Inc , Securities Exchange Commission , Jefferies Financial Group , Immuneering Co , Needham Company , Get Free Report , Exchange Commission , Stock Down , New York Mellon Corp , Vanguard Group , Financial Group , Investigational New Drug , Immuneering Daily ,